Royal Darwin Hospital is a 360-bed Australian teaching hospital located in Tiwi, Northern Territory, a northern suburb of the Territory capital Darwin. It is part of the Top End Health Service, which covers an area of 475,338 km².

There are 360 beds in Royal Darwin Hospital.

During the past decade, Royal Darwin Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 1 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Darwin Hospital" #1 sponsor was "Australian and New Zealand Intensive Care Research Centre" with 3 trials, followed by "Australasian Gastro-Intestinal Trials Group" with 2 trials sponsored, "University of Melbourne" with 2 trials sponsored, "Bayer" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Darwin Hospital" #1 collaborator was "National Health and Medical Research Council, Australia" with 4 trials as a collaborator, "Academic and Community Cancer Research United" with 2 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Health Research Board, Ireland" with 2 trials as a collaborator and "Medical Research Future Fund" with 2 trials as a collaborator. Other collaborators include 31 different institutions and companies that were collaborators in the rest 38 trials.

According to Clinical.Site data, the most researched conditions in "Royal Darwin Hospital" are "Gastro-Oesophageal Cancer" (2 trials), "Blunt Injury" (1 trials), "Colorectal Cancer" (1 trials), "Complication of Prematurity" (1 trials) and "Critical Illness and Mechanical Ventilation" (1 trials). Many other conditions were trialed in "Royal Darwin Hospital" in a lesser frequency.

Most popular intervention types in "Royal Darwin Hospital" are "Drug" (10 trials), "Other" (6 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Regorafenib" (2 trials), "Acetylsalicylic acid" (1 trials), "BAY2757556 (Larotrectinib, Vitrakvi)" (1 trials) and "Cefazolin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Royal Darwin Hospital" are 11 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Royal Darwin Hospital". 1 are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Royal Darwin Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Royal Darwin Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".